Director Of Business Development at Mitotherapeutix - Farmington, CT, US
Chief Scientific Officer
Contact Cynthia Arbeeny
Chief Executive Officer
Contact Jack Talley
TIP Fellow
Contact Josh Mednick
Steering Committee
Contact Mariluz Martinez-Chantar
Chief Operating Officer
Contact Bob Hemley
Mitotherapeutix was created to take advantage of advancements in RNA chemistry and its use in developing new drugs (siRNA) which can target "undruggable" disease targets.